Orano Med Inaugurates ATLab Valenciennes, Europe’s First Industrial Facility Dedicated to the Production of Lead-212-Based Targeted Alpha Therapies

Posted on by sHq_LoGiNz

VALENCIENNES, France–(BUSINESS WIRE)–Orano Med inaugurates ATLab Valenciennes, Europe’s first industrial facility dedicated to the production of lead-212-based targeted alpha therapies

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.